US Broker Ratings

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Healthcare Plans Landscape with a 4.48% ROE

In the intricate world of healthcare plans, Molina Healthcare Inc (NYSE: MOH) stands as a significant player with a market capitalization of $10.18 billion. Headquartered in Long Beach, California, Molina..

Becton, Dickinson and Company (BDX) Stock Analysis: Is a 25.5% Potential Upside Within Reach?

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is drawing investor attention with its potential upside of 25.5%, based on its average target price of $180.69...

Insmed Incorporated (INSM) Stock Analysis: Exploring a 105.79% Potential Upside in the Biotech Sector

Investors looking for opportunities in the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing candidate. With a market capitalization of $20.76 billion, Insmed operates from its headquarters in..

Boston Scientific Corporation (BSX) Stock Analysis: Potential 68.87% Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX), a renowned player in the healthcare sector specializing in medical devices, is capturing the attention of investors with a remarkable potential upside of 68.87%. With..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 260% Revenue Growth Amidst a Challenging Valuation Landscape

Investors looking into Moderna, Inc. (MRNA), a key player in the biotechnology industry, are faced with a complex evaluation of its current financial metrics and market position. Known for its..

Veeva Systems Inc. (VEEV) Stock Analysis: Unlocking Over 60% Potential Upside with Strong Analyst Support

For investors seeking robust opportunities in the healthcare technology sector, Veeva Systems Inc. (NYSE: VEEV) offers a compelling proposition. With a market capitalization of $24.9 billion, Veeva is a major..

Genmab A/S (GMAB) Stock Analysis: Biotechnology Giant Displays 45.7% Potential Upside

For investors keen on exploring opportunities in the healthcare sector, Genmab A/S (NASDAQ: GMAB) stands out as a compelling candidate. With a robust 45.7% potential upside, this Denmark-based biotechnology leader..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Prospects and Market Position in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has become a focal point for investors interested in the healthcare industry. With a market capitalization of $13.05 billion,..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 25% Potential Upside in Healthcare Innovation

In the dynamic world of healthcare technology, Koninklijke Philips N.V. (NYSE: PHG) stands out as a formidable player with a significant footprint. With its headquarters in Amsterdam, this Dutch multinational..

Insulet Corporation (PODD) Stock Analysis: A Strong Buy with 66% Upside Potential

Investors seeking opportunities in the healthcare sector may find Insulet Corporation (NASDAQ: PODD) to be an enticing prospect. The company, which specializes in innovative insulin delivery systems, has generated considerable..

Smith & Nephew SNATS, Inc. (SNN): Navigating Growth in the Medical Devices Sector with a 16.33% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a significant market capitalization of $12.72 billion,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 29.44% Potential Upside for Investors

In the ever-evolving landscape of healthcare technology, GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a significant player, particularly in the medical devices industry. With a market capitalization of $28.02..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring an 11.88% Potential Upside with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) stands as a distinctive player in the biotechnology industry, offering investors a unique opportunity to engage with the healthcare sector. Based in New York, this..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 26% Upside with Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specializes in diagnostics and research, primarily focusing on veterinary, livestock, and water quality testing. With a substantial market..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: A Healthcare Giant with a Potential 15.98% Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a stalwart in the Healthcare sector under the Diagnostics & Research industry, continues to capture investor attention with its robust global operations and promising financial..

The Cigna Group (CI) Stock Analysis: Uncovering a Promising 21.93% Upside Potential

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, continues to capture investor attention with its dynamic operations and robust market presence. With a current market capitalization of..

Agilent Technologies, Inc. (A) Stock Analysis: A 26.2% Upside Beckons in the Diagnostics & Research Arena

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors seeking growth and stability. With..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 104.97% Potential Upside in Biotechnology

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, is capturing significant attention from investors with its promising potential upside of 104.97%. Headquartered in Miami, Florida, Summit..

Tenet Healthcare Corporation (THC) Stock Analysis: A 41% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Tenet Healthcare Corporation (NYSE: THC) an intriguing prospect, especially with the potential for a significant 41.17% upside based on the average..

Bristol-Myers Squibb Company (BMY) Stock Analysis: Exploring the 16.81% Upside Potential for Investors

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector with a commanding market cap of $110.27 billion, continues to capture the attention of investors. With its strategic focus..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds